Tag: Matthew Levinstein
Ingenia eyes USD42m IPO as first US company listing in Korea
Ingenia Therapeutics’ KRW60 billion (USD42.4 million) IPO to become first listing of a US-based company in Korea
Ingenia Therapeutics’ KRW60 billion (USD42.4 million) IPO to become first listing of a US-based company in Korea
How can companies identify the right lawyer? A China Business Law Journal survey reveals what factors are truly driving the choices of general counsel
Follow us on LinkedIn